{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:04:18Z","timestamp":1769753058000,"version":"3.49.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010809","name":"Jascha Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejphar.2024.176434","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T17:08:44Z","timestamp":1709744924000},"page":"176434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Sildenafil, alone and in combination with imipramine or escitalopram, display antidepressant-like effects in an adrenocorticotropic hormone-induced (ACTH) rodent model of treatment-resistant depression"],"prefix":"10.1016","volume":"969","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0174-5242","authenticated-orcid":false,"given":"Juandr\u00e9 Lambertus","family":"Bernardus Saayman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian Herbert","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregers","family":"Wegener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2707-1258","authenticated-orcid":false,"given":"Christiaan Beyers","family":"Brink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejphar.2024.176434_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0031-9384(90)90306-O","article-title":"A possible alarm substance in the forced swimming test","volume":"48","author":"Abel","year":"1990","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2024.176434_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/PPA.S29716","article-title":"Treatment-resistant depression: therapeutic trends, challenges, and future directions","volume":"6","author":"Al-Harbi","year":"2012","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.ejphar.2024.176434_bib3","volume":"vol. 5","year":"2013"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176434_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.psyneuen.2010.03.007","article-title":"The glucocorticoid receptor: pivot of depression and of antidepressant treatment?","volume":"36","author":"Anacker","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ejphar.2024.176434_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yhbeh.2015.05.018","article-title":"Neuropeptide Y administration reverses tricyclic antidepressant treatment-resistant depression induced by ACTH in mice","volume":"73","author":"Antunes","year":"2015","journal-title":"Horm. Behav."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neulet.2010.10.074","article-title":"The phosphodiesterase type-5 inhibitor, tadalafil, improves depressive symptoms, ameliorates memory impairment, as well as suppresses apoptosis and enhances cell proliferation in the hippocampus of maternal-separated rat pups","volume":"488","author":"Baek","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176434_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/imm.12443","article-title":"Immune mechanisms linked to depression via oxidative stress and neuroprogression","volume":"144","author":"Bakunina","year":"2015","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.ejphar.2024.176434_bib8","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2174\/187152711798072347","article-title":"Nitric oxide, epileptic seizures, and action of antiepileptic drugs","volume":"10","author":"Banach","year":"2011","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.ejphar.2024.176434_bib9","article-title":"Acute effects of serotonergic antidepressants on tryptophan metabolism and corticosterone levels in rats","volume":"23","author":"Bano","year":"2010","journal-title":"Pak. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176434_bib10","first-page":"185","article-title":"Implication of the hypothalamic\u2013pituitary\u2013adrenal axis in the physiopathology of depression","volume":"29","author":"Barden","year":"2004","journal-title":"J. Psychiatr. Neurosci."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5127\/pr.034413","article-title":"The HPA axis in the pathogenesis and treatment of depressive disorders, Integrating clinical and molecular findings","volume":"3","author":"Baumeister","year":"2016","journal-title":"Psychopathology Review"},{"key":"10.1016\/j.ejphar.2024.176434_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jad.2018.04.016","article-title":"Treatment-resistant depression and suicidality","volume":"235","author":"Bergfeld","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/pcn.12604","article-title":"Neural basis of major depressive disorder: beyond monoamine hypothesis","volume":"72","author":"Boku","year":"2018","journal-title":"Psychiatr. Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176434_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","article-title":"Is the forced swimming test a suitable model for revealing antidepressant activity?","volume":"94","author":"Borsini","year":"1988","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.ejphar.2024.176434_bib15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1073\/pnas.0406458102","article-title":"Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior","volume":"102","author":"Boyle","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176434_bib16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/1570159X13666150307004545","article-title":"A review of biomarkers in mood and psychotic disorders: a dissection of clinical vs. preclinical correlates","volume":"13","author":"Brand","year":"2015","journal-title":"Curr. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176434_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/neu.2016.44","article-title":"Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression I: bio-behavioural validation and response to imipramine","volume":"29","author":"Brand","year":"2017","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.ejphar.2024.176434_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00702-007-0806-5","article-title":"Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies","volume":"115","author":"Brink","year":"2008","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ejphar.2024.176434_bib19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.neubiorev.2021.05.018","article-title":"The kynurenine pathway in major depression: what we know and where to next","volume":"127","author":"Brown","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176434_bib20","first-page":"245","article-title":"Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders, the role of vitagenes","volume":"18","author":"Calabrese","year":"2004","journal-title":"In Vivo"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176434_bib21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/pr.117.014977","article-title":"International union of basic and clinical pharmacology CIV, the neurobiology of treatment-resistant depression, from antidepressant classifications to novel pharmacological targets","volume":"70","author":"Caraci","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2024.176434_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1600-0447.2007.00967.x","article-title":"Pathophysiology of hypercortisolism in depression","volume":"115","author":"Carroll","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176434_bib23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000447034","article-title":"The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature","volume":"85","author":"Carvalho","year":"2016","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.ejphar.2024.176434_bib24","doi-asserted-by":"crossref","unstructured":"Cleveland Clinic, 2023. Treatment-Resistant Depression. Overview. What are the Symptoms of Treatment-Resistant Depression? https:\/\/my.clevelandclinic.org\/health\/diseases\/24991-treatment-resistant-depression.Dateofaccess, 2023-08-1..","DOI":"10.1016\/bs.pbr.2023.03.007"},{"key":"10.1016\/j.ejphar.2024.176434_bib25","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.ejphar.2024.176434_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10456-011-9211-7","article-title":"Cyclic GMP protects endothelial progenitors from oxidative stress","volume":"14","author":"Curatola","year":"2011","journal-title":"Angiogenesis"},{"issue":"4","key":"10.1016\/j.ejphar.2024.176434_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000104877","article-title":"Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test","volume":"80","author":"Dhir","year":"2007","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2024.176434_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jad.2019.11.114","article-title":"Phosphodiesterase-5 inhibitors: shedding new light on the darkness of depression?","volume":"264","author":"Duarte-Silva","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176434_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.ejphar.2024.176434_bib30","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176434_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1017\/S1461145709990721","article-title":"Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression","volume":"13","author":"Elfving","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.ejphar.2024.176434_bib32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/jdn.10224","article-title":"The protective effects of escitalopram on synaptic plasticity in the CA1 region of chronically stressed and non\u2010stressed male rats","volume":"82","author":"Farahbakhsh","year":"2022","journal-title":"Int. J. Dev. Neurosci."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176434_bib33","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.neuroscience.2005.06.051","article-title":"Distribution of cGMP-dependent protein kinase type I and its isoforms in the mouse brain and retina","volume":"135","author":"Feil","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2024.176434_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pscychresns.2017.10.001","article-title":"A pilot study of cortical glutathione in youth with depression","volume":"270","author":"Freed","year":"2017","journal-title":"Psychiatr. Res. Neuroimaging"},{"issue":"15","key":"10.1016\/j.ejphar.2024.176434_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2017.3826","article-title":"Depression is the leading cause of disability around the world","volume":"317","author":"Friedrich","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ejphar.2024.176434_bib36","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1055\/s-2003-43507","article-title":"The prototypic antidepressant drug, imipramine, but not Hypericum perforatum (St. John's Wort), reduces HPA-axis function in the rat","volume":"35","author":"Frost","year":"2003","journal-title":"Horm. Metab. Res."},{"issue":"18","key":"10.1016\/j.ejphar.2024.176434_bib37","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.4155\/bio-2016-0111","article-title":"LC\u2013MS\/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain","volume":"8","author":"Fuertig","year":"2016","journal-title":"Bioanalysis"},{"issue":"19","key":"10.1016\/j.ejphar.2024.176434_bib38","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1523\/JNEUROSCI.0374-11.2011","article-title":"Neuronal nitric oxide contributes to neuroplasticity-associated protein expression through cGMP, protein kinase G, and extracellular signal-regulated kinase","volume":"31","author":"Gallo","year":"2011","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S1461145710000805","article-title":"Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders","volume":"14","author":"Gawryluk","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2024.176434_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jpba.2016.02.001","article-title":"Icariin reverses corticosterone-induced depression-like behavior, decrease in hippocampal brain-derived neurotrophic factor (BDNF) and metabolic network disturbances revealed by NMR-based metabonomics in rats","volume":"123","author":"Gong","year":"2016","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ejphar.2024.176434_bib41","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jad.2020.05.101","article-title":"Predictors of cognitive impairment in treatment-resistant depression","volume":"274","author":"Gregory","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2024.176434_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pbb.2014.07.002","article-title":"Effects of aspirin on immobile behavior and endocrine and immune changes in the forced swimming test: comparison to fluoxetine and imipramine","volume":"124","author":"Guan","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2024.176434_bib43","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpsychires.2015.04.026","article-title":"Does escitalopram reduce neurotoxicity in major depression?","volume":"66","author":"Halaris","year":"2015","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176434_bib44","first-page":"309","article-title":"Affective disorders and nitric oxide: a role in pathways to relapse and refractoriness? Human Psychopharmacology","volume":"11","author":"Harvey","year":"1996","journal-title":"Clinical and Experimental"},{"issue":"5","key":"10.1016\/j.ejphar.2024.176434_bib45","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.physbeh.2006.01.033","article-title":"Cortical\/hippocampal monoamines, HPA-axis changes and aversive behavior following stress and restress in an animal model of post-traumatic stress disorder","volume":"87","author":"Harvey","year":"2006","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000343501","article-title":"Metabolic and glutathione redox markers associated with brain-derived neurotrophic factor in depressed African men and women: evidence for counterregulation?","volume":"67","author":"Harvey","year":"2012","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0024-3205(02)01561-8","article-title":"NMDA receptor involvement in imipramine withdrawal-associated effects on swim stress, GABA levels and NMDA receptor binding in rat hippocampus","volume":"71","author":"Harvey","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2024.176434_bib48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11011-006-9018-1","article-title":"Increased hippocampal nitric oxide synthase activity and stress responsiveness after imipramine discontinuation: role of 5HT 2A\/C-receptors","volume":"21","author":"Harvey","year":"2006","journal-title":"Metab. Brain Dis."},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2024.176434_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jad.2013.01.004","article-title":"Risk factors for suicide in individuals with depression: a systematic review","volume":"147","author":"Hawton","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.ejphar.2024.176434_bib50","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/biom12070998","article-title":"The role of tryptophan dysmetabolism and quinolinic acid in depressive and neurodegenerative diseases","volume":"12","author":"Hestad","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib51","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbr.2005.07.021","article-title":"Differential effects of ovarian steroids on anxiety versus fear as measured by open field test and fear-potentiated startle","volume":"166","author":"Hiroi","year":"2006","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176434_bib52","first-page":"387","article-title":"Novel strategies for treatment-resistant depression","volume":"19","author":"Hornig-Rohan","year":"1996","journal-title":"Psychiatr. Clin."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176434_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neulet.2011.02.030","article-title":"Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats","volume":"493","author":"Huang","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainres.2006.06.077","article-title":"Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat","volume":"1110","author":"Jacobsen","year":"2006","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.ejphar.2024.176434_bib55","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1177\/0269881113499205","article-title":"The role of mineralocorticoid receptor function in treatment-resistant depression","volume":"27","author":"Juruena","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2024.176434_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2024.176434_bib57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0091-3057(01)00625-6","article-title":"Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test","volume":"71","author":"Kitamura","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176434_bib58","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1248\/bpb.31.246","article-title":"Effects of imipramine and bupropion on the duration of immobility of ACTH-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA","volume":"31","author":"Kitamura","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176434_bib59","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.pharep.2018.01.004","article-title":"Prolonged therapy with antidepressants increases hippocampal level of kynurenic acid and expression of Kat1 and Kat2 genes","volume":"70","author":"Kocki","year":"2018","journal-title":"Pharmacol. Rep."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176434_bib60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4306\/pi.2010.7.4.231","article-title":"The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment","volume":"7","author":"Lee","year":"2010","journal-title":"Psychiatry investigation"},{"key":"10.1016\/j.ejphar.2024.176434_bib61","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jad.2018.09.062","article-title":"Quality of life across domains among individuals with treatment-resistant depression","volume":"243","author":"Lex","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176434_bib62","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1248\/yakushi.127.735","article-title":"Strategy to develop a new drug for treatment-resistant depression--role of electroconvulsive stimuli and BDNF","volume":"127","author":"Li","year":"2007","journal-title":"Yakugaku Zasshi: J. Pharm. Soc. Jpn."},{"key":"10.1016\/j.ejphar.2024.176434_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pbr.2023.03.007","article-title":"Overview of treatment-resistant depression","volume":"278","author":"Li","year":"2023","journal-title":"Prog. Brain Res."},{"issue":"12","key":"10.1016\/j.ejphar.2024.176434_bib64","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/bmc.3232","article-title":"Rapid determination of corticosterone in mouse plasma by ultra fast liquid chromatography\u2010tandem mass spectrometry","volume":"28","author":"Li","year":"2014","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib65","first-page":"89","article-title":"Serotonin of hippocampus and hypothalamus taking part in the analgesic effect of adrenocorticotropic hormone in rats","volume":"11","author":"Li","year":"1990","journal-title":"Zhongguo yao li xue bao= Acta Pharmacologica Sinica"},{"issue":"5\u20136","key":"10.1016\/j.ejphar.2024.176434_bib66","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/FBP.0b013e32833befe5","article-title":"Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression","volume":"21","author":"Liebenberg","year":"2010","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib67","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbr.2010.01.032","article-title":"Investigating the role of protein kinase-G in the antidepressant-like response of sildenafil in combination with muscarinic acetylcholine receptor antagonism","volume":"209","author":"Liebenberg","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176434_bib68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/acps.12122","article-title":"Pharmacological management of unipolar depression","volume":"127","author":"Malhi","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ejphar.2024.176434_bib69","series-title":"HPA axis Dysfunction in Treatment Resistant Affective Disorders","author":"Markopoulou","year":"2013"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.psyneuen.2008.08.004","article-title":"The ratio of cortisol\/DHEA in treatment resistant depression","volume":"34","author":"Markopoulou","year":"2009","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"10.1016\/j.ejphar.2024.176434_bib71","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1038\/s41380-020-00951-9","article-title":"The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies","volume":"26","author":"Marx","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176434_bib72","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/jpet.108.137208","article-title":"Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice","volume":"326","author":"Masood","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2024.176434_bib73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2011.11.001","article-title":"Antidepressant-like effect of sildenafil through oxytocin-dependent cyclic AMP response element-binding protein phosphorylation","volume":"200","author":"Matsushita","year":"2012","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib74","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0376-6357(86)90069-0","article-title":"Does neophobia necessarily imply fear or anxiety?","volume":"12","author":"Misslin","year":"1986","journal-title":"Behav. Process."},{"key":"10.1016\/j.ejphar.2024.176434_bib75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11011-010-9189-7","article-title":"Ozone modulates the effects of imipramine on immobility in the forced swim test, and nonspecific parameters of hippocampal oxidative stress in the rat","volume":"25","author":"Mokoena","year":"2010","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2024.176434_bib76","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1007\/s00213-015-3928-8","article-title":"Ozone exposure of Flinders Sensitive Line rats is a rodent translational model of neurobiological oxidative stress with relevance for depression and antidepressant response","volume":"232","author":"Mokoena","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2024.176434_bib77","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bbi.2012.12.011","article-title":"Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine","volume":"30","author":"M\u00f6ller","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"7","key":"10.1016\/j.ejphar.2024.176434_bib78","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1021\/cn5003368","article-title":"Neurodevelopmental animal models reveal the convergent role of neurotransmitter systems, inflammation, and oxidative stress as biomarkers of schizophrenia: implications for novel drug development","volume":"6","author":"Moller","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176434_bib79","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1007\/s00216-011-5322-7","article-title":"Development of an LC-MS\/MS method for the analysis of serotonin and related compounds in urine and the identification of a potential biomarker for attention deficit hyperactivity\/hyperkinetic disorder","volume":"401","author":"Moriarty","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176434_bib81","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.3390\/ijms23052552","article-title":"Modulation of inflammatory cytokine production in human monocytes by cGMP and IRAK3","volume":"23","author":"Nguyen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176434_bib82","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00702-013-1130-x","article-title":"Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder","volume":"121","author":"Niciu","year":"2014","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ejphar.2024.176434_bib83","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11011-017-0144-8","article-title":"Garcinia mangostana Linn displays antidepressant-like and pro-cognitive effects in a genetic animal model of depression: a bio-behavioral study in the flinders sensitive line rat","volume":"33","author":"Oberholzer","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2024.176434_bib84","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jad.2023.07.078","article-title":"The kynurenine pathway in major depressive disorder under different disease states, A systematic review and meta-analysis","volume":"339","author":"Ou","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1124\/pr.111.005397","article-title":"The flinders sensitive line rat model of depression\u201425 years and still producing","volume":"65","author":"Overstreet","year":"2013","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176434_bib86","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13739","article-title":"The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder","volume":"75","author":"\u00d6zt\u00fcrk","year":"2021","journal-title":"Int. J. Clin. Pract."},{"issue":"9","key":"10.1016\/j.ejphar.2024.176434_bib87","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","article-title":"The HPA axis in major depression: classical theories and new developments","volume":"31","author":"Pariante","year":"2008","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176434_bib88","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1017\/neu.2019.25","article-title":"Esketamine and rapastinel, but not imipramine, have antidepressant-like effect in a treatment-resistant animal model of depression","volume":"31","author":"Pereira","year":"2019","journal-title":"Acta Neuropsychiatr."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176434_bib89","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial","volume":"176","author":"Phillips","year":"2019","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejphar.2024.176434_bib90","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","article-title":"BDNF as a biomarker for successful treatment of mood disorders: a systematic, quantitative meta-analysis","volume":"174","author":"Polyakova","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176434_bib91","first-page":"139","article-title":"Animal model of depression","volume":"30","author":"Porsolt","year":"1979","journal-title":"Biomedicine\/[publiee pour l'AAICIG]"},{"issue":"5604","key":"10.1016\/j.ejphar.2024.176434_bib92","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ejphar.2024.176434_bib93","first-page":"3158","article-title":"Clinical review of recent findings on the awareness, diagnosis and treatment of depression","volume":"61","author":"Preboth","year":"2000","journal-title":"Am. Fam. Physician"},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2024.176434_bib94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib95","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-4328(96)00164-7","article-title":"A multiple-test study of anxiety-related behaviours in six inbred rat strains","volume":"85","author":"Ramos","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176434_bib96","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainresbull.2014.04.002","article-title":"Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes","volume":"104","author":"Rap\u00f4so","year":"2014","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176434_bib97","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2174\/157015911798376271","article-title":"cGMP signaling, phosphodiesterases and major depressive disorder","volume":"9","author":"Reierson","year":"2011","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib98","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pharmthera.2006.07.002","article-title":"Differentiating antidepressants of the future: efficacy and safety","volume":"113","author":"Rosenzweig-Lipson","year":"2007","journal-title":"Pharmacol. Therapeut."},{"issue":"11","key":"10.1016\/j.ejphar.2024.176434_bib99","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps, a STAR* D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176434_bib100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1176\/foc.6.1.foc128","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report","volume":"6","author":"Rush","year":"2008","journal-title":"Focus"},{"issue":"4","key":"10.1016\/j.ejphar.2024.176434_bib101","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/neu.2021.4","article-title":"The long-term bio-behavioural effects of juvenile sildenafil treatment in Sprague-Dawley versus flinders sensitive line rats","volume":"33","author":"Saayman","year":"2021","journal-title":"Acta Neuropsychiatr."},{"issue":"6","key":"10.1016\/j.ejphar.2024.176434_bib102","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1476-5381.2011.01489.x","article-title":"Antidepressant\u2010like effect induced by systemic and intra\u2010hippocampal administration of DNA methylation inhibitors","volume":"164","author":"Sales","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176434_bib103","article-title":"Effects of imipramine on serum corticosterone levels in the forced swimming rats","author":"Satoh","year":"1985","journal-title":"Res. Commun. Psychol. Psychiatr. Behav."},{"key":"10.1016\/j.ejphar.2024.176434_bib104","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2015.02.007","article-title":"Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder","volume":"46","author":"Savitz","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2024.176434_bib105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbr.2017.01.043","article-title":"Long-lasting effects of fluoxetine and\/or exercise augmentation on bio-behavioural markers of depression in pre-pubertal stress sensitive rats","volume":"323","author":"Schoeman","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176434_bib106","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.mp.4000197","article-title":"Nitric oxide: a spatial second messenger","volume":"2","author":"Schulman","year":"1997","journal-title":"Mol. Psychiatr."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176434_bib107","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/eb-2016-102355","article-title":"Ketamine for treatment-resistant depression, recent developments and clinical applications","volume":"19","author":"Schwartz","year":"2016","journal-title":"Evid. Base Ment. Health"},{"issue":"2","key":"10.1016\/j.ejphar.2024.176434_bib108","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/0023677217724823","article-title":"PREPARE: guidelines for planning animal research and testing","volume":"52","author":"Smith","year":"2018","journal-title":"Lab. Anim"},{"issue":"5","key":"10.1016\/j.ejphar.2024.176434_bib109","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s11011-016-9852-8","article-title":"Antidepressant-like activity of sildenafil following acute and subchronic treatment in the forced swim test in mice: effects of restraint stress and monoamine depletion","volume":"31","author":"Soca\u0142a","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2024.176434_bib110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainresbull.2021.09.002","article-title":"Antidepressant effect of catalpol on corticosterone-induced depressive-like behavior involves the inhibition of HPA axis hyperactivity, central inflammation and oxidative damage probably via dual regulation of NF-\u03baB and Nrf2","volume":"177","author":"Song","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2024.176434_bib111","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpba.2012.08.013","article-title":"Direct glutathione quantification in human blood by LC\u2013MS\/MS: comparison with HPLC with electrochemical detection","volume":"71","author":"Squellerio","year":"2012","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ejphar.2024.176434_bib112","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbr.2018.05.021","article-title":"Immediate and long-term antidepressive-like effects of pre-pubertal escitalopram and omega-3 supplementation combination in young adult stress-sensitive rats","volume":"351","author":"Steyn","year":"2018","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176434_bib113","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1152\/jn.01048.2006","article-title":"Modulation of serotonergic neurotransmission by nitric oxide","volume":"97","author":"Straub","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2024.176434_bib114","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbi.2020.01.011","article-title":"The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine","volume":"87","author":"Sun","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.ejphar.2024.176434_bib115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/acps.12874","article-title":"Recurrence and chronicity of major depressive disorder and their risk indicators in a population cohort","volume":"137","author":"Ten Have","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ejphar.2024.176434_bib116","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuroscience.2014.03.025","article-title":"Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice","volume":"268","author":"Tomaz","year":"2014","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.ejphar.2024.176434_bib117","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/da.22695","article-title":"Seeing the signs, Using the course of residual depressive symptomatology to predict patterns of relapse and recurrence of major depressive disorder","volume":"35","author":"Verhoeven","year":"2018","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.ejphar.2024.176434_bib118","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/NDT.S198774","article-title":"Management of treatment-resistant depression: challenges and strategies","author":"Voineskos","year":"2020","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.ejphar.2024.176434_bib119","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2012.12.033","article-title":"Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levels","volume":"242","author":"Walker","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176434_bib120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11011-014-9533-4","article-title":"Antidepressant-like effects of the phosphodiesterase-4 inhibitor etazolate and phosphodiesterase-5 inhibitor sildenafil via cyclic AMP or cyclic GMP signaling in mice","volume":"29","author":"Wang","year":"2014","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2024.176434_bib121","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jchromb.2019.02.021","article-title":"LC-MS\/MS-based quantification of tryptophan metabolites and neurotransmitters in the serum and brain of mice","volume":"1112","author":"Wang","year":"2019","journal-title":"J. Chromatogr. B"},{"issue":"10","key":"10.1016\/j.ejphar.2024.176434_bib122","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.neubiorev.2012.12.007","article-title":"The neurobiology of depression and antidepressant action","volume":"37","author":"Willner","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2024.176434_bib123","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.dib.2016.03.025","article-title":"Data supporting the rat brain sample preparation and validation assays for simultaneous determination of 8 neurotransmitters and their metabolites using liquid chromatography\u2013tandem mass spectrometry","volume":"7","author":"Wojnicz","year":"2016","journal-title":"Data Brief"},{"issue":"4","key":"10.1016\/j.ejphar.2024.176434_bib125","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/bmc.3316","article-title":"Development and validation of a highly sensitive LC\u2010MS\/MS method for the determination of dexamethasone in nude mice plasma and its application to a pharmacokinetic study","volume":"29","author":"Yuan","year":"2015","journal-title":"Biomed. Chromatogr."},{"issue":"6","key":"10.1016\/j.ejphar.2024.176434_bib126","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1046\/j.1471-4159.1997.69062477.x","article-title":"High serotonin and 5\u2010hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment","volume":"69","author":"Zangen","year":"1997","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176434_bib127","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-8993(99)01214-7","article-title":"Increased catecholamine levels in specific brain regions of a rat model of depression: normalization by chronic antidepressant treatment","volume":"824","author":"Zangen","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2024.176434_bib128","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fpsyt.2015.00172","article-title":"Treatment-resistant major depression: rationale for NMDA receptors as targets and nitrous oxide as therapy","volume":"6","author":"Zorumski","year":"2015","journal-title":"Front. Psychiatr."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924001225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924001225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T05:14:03Z","timestamp":1734412443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":126,"alternative-id":["S0014299924001225"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176434","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sildenafil, alone and in combination with imipramine or escitalopram, display antidepressant-like effects in an adrenocorticotropic hormone-induced (ACTH) rodent model of treatment-resistant depression","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176434"}}